Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

TDM of Generic Lopinavir/Ritonavir 200/50 mg

This study has been completed.
Sponsor:
Collaborator:
The Government Pharmaceutical Organization
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT00802334
First received: May 29, 2008
Last updated: March 24, 2015
Last verified: March 2015